We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

19 May 2026 - 22 May 2026
17 Jun 2026 - 19 Jun 2026
05 Oct 2026 - 06 Oct 2026

Embolization Treatment for Uterine Fibroids

By HospiMedica staff writers
Posted on 30 Jul 2003
Symptomatic fibroid tumors can be treated with uterine fibroid embolization (UFE), a minimally invasive procedure that may reduce the number of uterine surgeries.

UFE can be used as an alternative to both hysterectomy and myomectomy. More...
An interventional radiologist injects small, specially engineered particles into the uterine arteries that supply blood to the fibroid. Once the particles stop the flow of blood to the fibroid, the tumor shrinks and symptoms are relieved. Usually, the fibroid shrinks to half its original size within the first three months following UFE. Because embolization is a permanent treatment, it is unusual for tumor regrowth to occur.

"Between 85-90% of UFE patients report reduced or completely alleviated symptoms and are happy with the procedure and its results,” noted Dr. Robert Vogelzang, professor and chief of vascular and interventional radiology at Northwestern University Medical School (Chicago, IL, USA; www.nums.nwu.edu). Dr. Vogelzang spoke about the procedure during a media briefing by the Radiological Society of North America (RSNA) in New York (NY, USA).

Patients with excessively large fibroids, fibroids outside the uterus, or active infections are not good UFE candidates. Long-term studies are needed to determine if UFE is uniformly safe for women who wish to become pregnant. A multicenter study indicated that successful pregnancies can occur after UFE.




Related Links:
Northwestern

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Resorbable Bovine Collagen Membrane
GenDerm
New
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.